Loading data for ELOX — first visit, this takes a few seconds.
Eloxx Pharmaceuticals Inc... (ELOX)
NasdaqCM: ELOX
· リアルタイム株価 · USD
18.25
-0.22 (-1.19%)
終値時点: Aug 18, 2026, 3:59 PM
Eloxx Pharmaceuticals Inc. (ELOX) Stock Price, Analysis & Data
-1.19% (1D)
ELOXについて
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates that modulate the ribosome and promote readthrough of premature stop codons caused by nonsense mutations in the United States, Israel, and Australia. The company is developing exaluren, a eukaryotic ribosome-selective glycoside in a Phase 2 trial for the treatment of rare kidney diseases, including Alport syndrome with nonsense muta...
セクター Healthcare
IPO日 Jun 9, 2026
従業員数 10
上場取引所 NasdaqCM
ティッカー ELOX
ウェブサイト https://www.eloxxpharma.com
決算サプライズ
Eloxx PharmaceuticalsはNov 13, 2023に四半期決算を発表しました:
